Metformin dosing related to renal clearance in outpatients: The MetClear study
Completed
- Conditions
- diabetes mellitus type II10018424
- Registration Number
- NL-OMON35525
- Lead Sponsor
- Medisch Centrum Haaglanden
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
diagnosis of diabetes mellitus type II, treatment with metformin
Exclusion Criteria
no diabetes mellitus type II, treatment without metformin, participation in other study with blinded study drug
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>To gain a better insight in metformin dose and adjustments to renal clearance.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Correlation between metformin dose, renal clearance (MDRD), metformin and<br /><br>lactic acid concentration in blood.</p><br>